Joseph Rizzo

Rule Changes

Calling for more research in broader populations

On November 9, the US Food and Drug Administration told every maker of a GLP-1 drug to add a warning about a rare eye condition to its label. The condition is nonarteritic anterior ischemic optic neuropathy, or NAION: a loss of blood flow to the optic nerve that can permanently blind one eye, usually without pain.

Updated 1 hour ago